Quick Answer
Centessa Pharmaceuticals plc reported Operating Income of -$207.69 million for fiscal year 2025.
Centessa Pharmaceuticals plc Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$207.69M | -3.3% |
| 2024 | -$201.06M | -17.4% |
| 2023 | -$171.28M | +19.3% |
| 2022 | -$212.26M | +43.3% |
| 2021 | -$374.08M | -47675.7% |
| 2021 | -$783.0K | +92.5% |
| 2020 | -$10.44M | -106.6% |
| 2019 | -$5.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$53.79M | -15.9% | +1.6% |
| June 30, 2025 | -$54.65M | -24.3% | -77.6% |
| March 31, 2025 | -$30.78M | +14.7% | +33.7% |
| September 30, 2024 | -$46.41M | -15.4% | -5.5% |
| June 30, 2024 | -$43.98M | +6.5% | -21.9% |
| March 31, 2024 | -$36.09M | +26.2% | +10.2% |
| September 30, 2023 | -$40.21M | +18.0% | +14.5% |
| June 30, 2023 | -$47.02M | +31.3% | +3.8% |
- Centessa Pharmaceuticals plc showed a decrease of -3.3% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Centessa Pharmaceuticals plc’s operating income has declined by 4010.3% (from -$5.05 million to -$207.69 million).
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: